CathVision

Our team at #CathVision is passionate about demonstrating how #SignalsMatter in real-world procedures using our #ECGenius advanced recording system! 👏 *With a mean baseline noise of just 0.008 mV (range: 0.006 to 0.015 mV), our #ECGenius system delivers unparalleled signal clarity—more than 7 times lower than the LabSystem Pro (0.060 mV, range: 0.040 to 0.090 mV). 🔎 In a recent ventricular tachycardia case, our #ECGenius advanced recording system was crucial in identifying late fractionated potentials, which might otherwise be lost in the baseline of older recording systems. 🫀 Check out the exciting image below! A 2 Fr catheter and a unipolar wire were used to identify late fractionated potentials, indicating a ventricular tachycardia (VT) pathway through the lateral branch of the anterior interventricular (AIV) artery. The best part? The procedure was a success, completely eliminating these potentials! *Habel et al., (2023) “Improved Visualization of Low Amplitude Late Potentials with VT Substrate Mapping Using a Novel EP Recording System,” Heart Rhythm, Vol 20, No 5S, May Supplement 2023. The #ECGenius is approved for sale in the US and CE marked in Europe, but it is not approved for sale in the rest of the world.

We are proud to announce today CE Mark certification for our ECGenius System. ECGenius System is a cutting-edge medical device designed to provide accurate real-time electrogram recording. The quality data enables a number of state-of-the-art AI-based analytics to run on the system, enhancing clinical decision making towards patient safety, outcomes and procedural efficiency. CathVision is starting commercialization in Europe in the coming quarters, in addition to the existing customer base in the US. https://lnkd.in/dXaSQN_3

At #CathVision, we proudly demonstrate the clinical benefits of our #ECGenius system's low-noise baseline, illustrating how #SignalsMatter, in everyday cases! 👏 Our top-notch signal quality results in an impressive *90% reduction in unipolar noise and a *39% reduction in bipolar recordings. This enhancement allows for precise and effective visualization of low-amplitude late potentials. 🔎 In this VT case, the comparison below illustrates how a noisy baseline in legacy recording systems can easily obscure low-amplitude late and fractionated potentials. 🫀 However, with #ECGenius, these same potentials are seen with precision and accuracy! The electrograms seen below were recorded at the same sweep speed and similar amplification scales. *Bazzi et al. (2024)” Ultra-Low Baseline Noise and Improved Signal Detection Using a Novel Intracardiac Electrogram Recording System,” 2024 AF Symposium Abstract.   The ECGenius System is cleared for sale in the US and not approved for sale in the rest of the world.

At CathVision, we're thrilled to embark on another incredible year in electrophysiology! Connecting with our amazing #EPeeps community, colleagues, and partners at the 30th annual #AFibSymposium2025 is just the beginning! 🫀 Come visit us at booth 305 to discover our latest groundbreaking science and innovations in advanced EP recording with #ECGenius! 🔬 #innovation #signalsmatter https://lnkd.in/e-hDmmt3

It’s time to upgrade EP recording. Connect now to evaluate the ECGenius System: https://lnkd.in/gwRyr_BS ECGenius System is cleared for sale in the US. Not approved for sale in the rest of the world.

The ECGenius™ System combines proprietary hardware technology and advanced software to acquire and record clinical data through a patented amplifier design. Learn more: www.cathvision.com #medtech #cardiology #healthcare #genius ECGenius System is cleared for sale in the US. Not approved for sale in the rest of the world.

➡ What is the impact of signal noise when visualizing and interpreting intracardiac data? Significant. Earlier this year, data published from the University of Vermont demonstrated how ECGenius System, CathVision's advanced EP recording technology and amplifier, is reducing noise to help EPs map complex arrhythmias and target ablation sites. Check out the details below ⬇️ #healthcareinnovation #epeeps #clinicaldata #cardiology ECGenius System is cleared for sale in the US. Not approved for sale in the rest of the world.

We at #CathVision are excited to announce our latest #ECGenius system update, which includes EMR integration and the generation of electrophysiology reports! #innovation https://lnkd.in/ejd5xnXK

🫀We are moving into a sphere where procedures are going to be faster, which is good for patients. Procedures are going to be safer, which is very good for patients. And, there will be better outcomes.🫀 #EPExpertise: Dr. Atul Verma discusses the physiology of electrical signals and the potential need and benefit of more closely examining unipolar signals as cardiac arrhythmia treatment continues to evolve. #PFA #cardiology #EP #medtech

CathVision is committed to developing electrophysiology solutions centered around an innovative EP recording system and AI-based analytic tools. Learn how ECGenius System is changing how EP’s see cardiac signal data: www.cathvision.com. #medtech #innovation #cardiology ECGenius System is cleared for sale in the US. Not approved for sale in the rest of the world